MARK JANOFSKI: Open Payments
NPI 1447548037 · ESCANABA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 6 payments from 6 companies in 2025. Trend: 2023 $419 · 2024 $425 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $61 |
| Medtronic, Inc. | 1 | $46 |
| Dexcom, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $13 |
Products named: Fabhalta, SYMPLICITY G3, Dexcom G6 Transmitter, JARDIANCE, TAVNEOS.
Industry payments across MI — which companies pay providers there.
